Related Experiment Videos
Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal
Clinical Pharmacology and Therapeutics
|April 1, 1984
Abstract:
Nine male heroin addicts maintained on L-alpha-acetylmethadol (LAAM) for about 5 mo had normal plasma levels of testosterone and luteinizing hormone 72 hr after a dose of LAAM and also during 2 wk after abrupt LAAM withdrawal.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Involvement of the Spinal Cord in Primary Mitochondrial Disorders: A Neuroimaging Mimicker of Inflammation and Ischemia in Children.
AJNR. American journal of neuroradiology·2021
The Perirolandic Sign: A Unique Imaging Finding Observed in Association with Polymerase γ-Related Disorders.
AJNR. American journal of neuroradiology·2020
Exposure-Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Cancer.
Clinical pharmacology and therapeutics·2026
Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.
Clinical pharmacology and therapeutics·2026
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Clinical pharmacology and therapeutics·2026
The Governance Gap: Democratizing Drug Development Through Decision Architecture.
Clinical pharmacology and therapeutics·2026
Evaluation of the Effect of Cendakimab on the Pharmacokinetics of CYP Probe Drugs in Patients With Eosinophilic Esophagitis.
Clinical and translational science·2026
Synthesis and Hepatotoxicity Evaluation of Paeonol Clofibrate.
Chemistry & biodiversity·2026
Shape-Restricted Detection of Natural Product Hormesis: A Re-Analysis of Complex Botanical Mixtures.
Dose-response : a publication of International Hormesis Society·2026
Aptamer-Functionalized DNA Frameworks as Targeted Drug Buffers for Concentration Regulation of Maytansine.
ACS applied bio materials·2026